Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Inflammasome and immune disorders, NF-κB Signaling Pathways, Hepatocellular Carcinoma Treatment and Prognosis, and Genomics, phytochemicals, and oxidative stress.
Characterization of H9N2 avian influenza virus isolated from chickens and waterfowl in parts of Southern China from 2018 to April 2024
Comparison of Postoperative Prognosis Among HBV-Related, HCV-Related, and Non-HBV Non-HCV Hepatocellular Carcinomas: A Systematic Review and Meta-analysis
Dicer induced reactive oxygen species inhibit hepatocellular carcinoma through interacting with cytochrome c oxidase
Sinomenine protects bone from destruction to ameliorate arthritis via activating p62Thr269/Ser272-Keap1-Nrf2 feedback loop
IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα
Muscle density discriminates hip fracture better than computed tomography X‐ray absorptiometry hip areal bone mineral density
Is Budd–Chiari Syndrome Associated to Alcoholic Related Liver Cirrhosis
Relationship between the mutations in precore/core region of hepatitis B virus gene and the postoperative survival in hepatocellular carcinoma
Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy
Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase/Akt-dependent mechanism
Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling
miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma
Effect of zinc deficiency on mouse renal interstitial fibrosis in diabetic nephropathy
Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma
X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma